Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation-Reference-Cited by-同舟云学术

Molsidomine provides neuroprotection against vincristine-induced peripheral neurotoxicity through soluble guanylyl cyclase activation

Published:2024-08-20 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Utkina-Sosunova Irina,Chiorazzi Alessia,de Planell-Saguer Mariangels,Li Hai,Meregalli Cristina,Pozzi Eleonora,Carozzi Valentina Alda,Canta Annalisa,Monza Laura,Alberti Paola,Fumagalli Giulia,Karan Charles,Moayedi Yalda,Przedborski Serge,Cavaletti Guido,Lotti Francesco

Funder

Fondazione Cariplo

Associazione Italiana per la Ricerca sul Cancro

Italian Ministry of Research National Research

Thompson Family Foundation Initiative at Columbia University

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-70294-w.pdf

Reference81 articles.

1. Alberti, P. et al. Neurological complications of conventional and novel anticancer treatments. Cancers https://doi.org/10.3390/cancers14246088 (2022).

2. Boyette-Davis, J. A., Walters, E. T. & Dougherty, P. M. Mechanisms involved in the development of chemotherapy-induced neuropathy. Pain Manag. 5, 285–296. https://doi.org/10.2217/pmt.15.19 (2015).

3. Cavaletti, G. & Marmiroli, P. Chemotherapy-induced peripheral neurotoxicity. Curr Opin Neurol 28, 500–507. https://doi.org/10.1097/WCO.0000000000000234 (2015).

4. Corbin, Z. A. et al. Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of mycosis fungoides and sezary syndrome. J. Neurooncol. 132, 439–446. https://doi.org/10.1007/s11060-017-2389-9 (2017).

5. Vahdat, L. T. et al. Ixabepilone-associated peripheral neuropathy: Data from across the phase II and III clinical trials. Supp. Care Cancer 20, 2661–2668. https://doi.org/10.1007/s00520-012-1384-0 (2012).